[1]
HuongN.T.T. and QuảngL.V. 2021. Assessment of the toxicities of sorafenib in patients with hepatocelular carcinoma. Tạp chí Y Dược lâm sàng 108. 17, DB (Apr. 2021). DOI:https://doi.org/10.52389/ydls.v17iDB.1281.